Cargando…
Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 Outbreak
BACKGROUND: COVID‐19 was temporally associated with an increase in out‐of‐hospital cardiac arrests, but the underlying mechanisms are unclear. We sought to determine if patients with implantable defibrillators residing in areas with high COVID‐19 activity experienced an increase in defibrillator sho...
Autores principales: | Adabag, Selçuk, Zimmerman, Patrick, Black, Adam, Madjid, Mohammad, Safavi‐Naeini, Payam, Cheng, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483533/ https://www.ncbi.nlm.nih.gov/pubmed/34044586 http://dx.doi.org/10.1161/JAHA.120.019708 |
Ejemplares similares
-
Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017) -
An “UninTENSional” Subcutaneous Implantable Cardioverter-defibrillator Shock
por: Turner, Suzette L., et al.
Publicado: (2018) -
Inappropriate subcutaneous implantable cardioverter-defibrillator shocks for bradycardia
por: Chua, Kelvin C.M., et al.
Publicado: (2021) -
Management of implantable cardioverter-defibrillator patients with appropriate ICD shocks: A 3-step treatment concept
por: Kleemann, Thomas, et al.
Publicado: (2021) -
Implantable cardioverter-defibrillators /
Publicado: (1994)